Roche's Webcast Replay on data presented at AAN 2019

Roche has hosted a live audio webcast and conference call on Monday, 13 May 2019.

Welcome
Karl Mahler, Head of Investor Relations
Overview of Roche key data at AAN covering new analysis from Ocrevus, satralizumab SakuraSky phase III data, risdiplam one year part I FIREFISH and SUNFISH data and dose selection data for the phase III study in Huntington's Disease
Paulo Fontoura, Global Head Neuroscience and Rare Diseases Clinical Development
Roche Neuroscience and Rare Disease franchise update
Karsten Jung, Therapeutic Area Head Neuroscience and Rare Diseases
Q&A

Please register to access the webcast

First Name

Last name

Corporate Email

Company Name

Job Role

Country

* Mandatory

Please come back 30 minutes before the webcast start date and fill in the registration form.